Mef2d potentiates type-2 immune responses and allergic lung inflammation
Science · 28.06.2024 · 384 (6703)
DOI: 10.1126/science.adl0370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 28.06.2024. Verfasst von Aydan C H Szeto und 13 weiteren Autor:innen. Beteiligte Einrichtung: MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK. Hauptthemen laut MEDLINE: MEF2 Transcription Factors, Th2 Cells, Immunity, Innate, Interleukin-33. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Innate lymphoid cells (ILCs) and adaptive T lymphocytes promote tissue homeostasis and protective immune responses. Their production depends on the transcription factor GATA3, which is further elevated specifically in ILC2s and T helper 2 cells to drive type-2 immunity during tissue repair, allergic disorders, and anti-helminth immunity. The control of this crucial up-regulation is poorly understood. Using CRISPR screens in ILCs we identified previously unappreciated myocyte-specific enhancer factor 2d (Mef2d)-mediated regulation of GATA3-dependent type-2 lymphocyte differentiation. Mef2d-deletion from ILC2s and/or T cells specifically protected against an allergen lung challenge. Mef2d repressed Regnase-1 endonuclease expression to enhance IL-33 receptor production and IL-33 signaling and acted downstream of calcium-mediated signaling to translocate NFAT1 to the nucleus to promote type-2 cytokine-mediated immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.
- Cambridge University Hospitals, Cambridge, CB2 0QQ, UK.
- School of Medicine, Trinity College Dublin, Dublin, Ireland.
Förderung
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Szeto, A. C. H., Clark, P. A., Ferreira, A. C. F., Heycock, M., Griffiths, E. L., Jou, E., Mannion, J., Luan, S. L., Storrar, S., Knolle, M. D., Kozik, P., Jolin, H. E., Fallon, P. G., & McKenzie, A. N. J. (2024). Mef2d potentiates type-2 immune responses and allergic lung inflammation. Science, 384(6703). https://doi.org/10.1126/science.adl0370
Vancouver
Szeto ACH, Clark PA, Ferreira ACF, Heycock M, Griffiths EL, Jou E, et al. Mef2d potentiates type-2 immune responses and allergic lung inflammation. Science. 2024;384(6703). doi:10.1126/science.adl0370
BibTeX
@article{Szeto2024,
author = {Szeto, Aydan C H and Clark, Paula A and Ferreira, Ana C F and Heycock, Morgan and Griffiths, Emma L and Jou, Eric and Mannion, Jonathan and Luan, Shi-Lu and Storrar, Sophie and Knolle, Martin D and Kozik, Patrycja and Jolin, Helen E and Fallon, Padraic G and McKenzie, Andrew N J},
title = {Mef2d potentiates type-2 immune responses and allergic lung inflammation},
journal = {Science},
year = {2024},
volume = {384},
number = {6703},
doi = {10.1126/science.adl0370}
}
EUVIMED